COVID-19 vaccine in development: Analysis from a Catholic perspective | EWTN News Nightly

As the US reportedly reaches nearly 4 million cases of COVID-19, President Trump has announced an agreement with pharmaceutical giant Pfizer to procure hundreds-of-millions of doses of its COVID-19 vaccine.

Dr. Paul Cieslak, infectious disease specialist and a member of the Catholic Medical Association USA), discusses what we know about the vaccine in development and what the faithful should keep in mind.